ArticleSubstance abuse : research and treatment2017
Moving on From Representativeness: Testing the Utility of the Global Drug Survey.
Article in Substance abuse : research and treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed.
- Impact of partial cannabis legalisation in Luxembourg: An interdisciplinary perspective.Drug and alcohol dependence reports · 2026Article
- Self-treatment of psychiatric conditions using ketamine: Patterns, characteristics, and retrospective insights.Journal of psychopharmacology (Oxford, England) · 2026Article
- The Trenbolo(g)ne Sandwich: An International Study Comparing Health Harms Among Men Who Use Anabolic-Androgenic Steroids With and Without Trenbolone.Drug and alcohol review · 2026Article
- From dust till dawn: patterns, motives, and risks of using smokable synthetic cathinones.Harm reduction journal · 2026Observational
- Understanding Age-Based Differences in Psychosocial Harms, Physical Harms, and Access Difficulties Among an International Sample of Men Who Use Anabolic-Androgenic Steroids.American journal of lifestyle medicine · 2025Article
- Relationships Between Motives for Cannabis and Cannabidiol Use in People Who Co-Use: Results From the European Web Survey on Drugs.Drug and alcohol review · 2025Article
- Determinants of Digital Health Literacy: International Cross-Sectional Study.Journal of medical Internet research · 2025Article
- Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany.Scientific reports · 2025Article
- Barriers to the use of no and low alcohol products in high-risk drinkers.Drug and alcohol review · 2025Article
- Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.Journal of psychopharmacology (Oxford, England) · 2025Article
- Clearing the air: Heightened perception of harm from secondhand cannabis smoke exposure is associated with no in-home cannabis smoking in a 21-country convenience sample.Preventive medicine · 2024Article
- The use of online methods to recruit and follow a hard-to-reach population in the Peer Alternatives for Addiction Study 2021 Cohort.Alcohol, clinical & experimental research · 2024Article
- From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions.Journal of psychopharmacology (Oxford, England) · 2024Article
- Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights.Journal of psychopharmacology (Oxford, England) · 2024Article
- Designing and implementing an experimental survey on knowledge and perceptions about alcohol warning labels.International journal of methods in psychiatric research · 2024Article
- Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).Harm reduction journal · 2024Article
- Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.Journal of psychopharmacology (Oxford, England) · 2023Article
- Experience and perpetration of intimate partner violence and abuse by gender of respondent and their current partner before and during COVID-19 restrictions in 2020: a cross-sectional study in 13 countries.BMC public health · 2023Article
- Vaping in a Time of Pandemics: Risk Perception and Motivations for Electronic Cigarette Use.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- Social Network Ties and Responses to COVID-19 Among E-Cigarette Users.Journal of drug issues · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A decline in response rates in traditional household surveys, combined with increased internet coverage and decreased research budgets, has resulted in increased attractiveness of web survey research designs based on purposive and voluntary opt-in sampling strategies. In the study of hidden or stigmatised behaviours, such as cannabis use, web survey methods are increasingly common. However, opt-in web surveys are often heavily criticised due to their lack of sampling frame and unknown representativeness. In this article, we outline the current state of the debate about the relevance of pursuing representativeness, the state of probability sampling methods, and the utility of non-probability, web survey methods especially for accessing hidden or minority populations. Our article has two aims: (1) to present a comprehensive description of the methodology we use at Global Drug Survey (GDS), an annual cross-sectional web survey and (2) to compare the age and sex distributions of cannabis users who voluntarily completed (a) a household survey or (b) a large web-based purposive survey (GDS), across three countries: Australia, the United States, and Switzerland. We find that within each set of country comparisons, the demographic distributions among recent cannabis users are broadly similar, demonstrating that the age and sex distributions of those who volunteer to be surveyed are not vastly different between these non-probability and probability methods. We conclude that opt-in web surveys of hard-to-reach populations are an efficient way of gaining in-depth understanding of stigmatised behaviours and are appropriate, as long as they are not used to estimate drug use prevalence of the general population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.